Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03175224
Title APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Apollomics Inc.
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Bozitinib

Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | CAN | AUS

Additional content available in CKB BOOST